CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $447.14 | $671K | 2,630 |
| 2025-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −541 | $448.43 | $243K | 2,089 |
| 2025-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,459 | $450.23 | $657K | 630 |
| 2025-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $451.29 | $226K | 130 |
| 2025-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 138,000 | ||
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −642 | $447.34 | $287K | 47,139 |
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,143 | $448.56 | $513K | 45,996 |
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,441 | $449.46 | $1.5M | 42,555 |
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,247 | $450.64 | $1.0M | 40,308 |
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,849 | $451.57 | $835K | 38,459 |
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,285 | $452.33 | $581K | 37,174 |
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −393 | $454.15 | $178K | 36,781 |
| 2025-10-30 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 22,000 | ||
| 2025-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,100 | $433.31 | $477K | 3,030 |
| 2025-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $435.24 | $870K | 1,030 |
| 2025-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −900 | $439.99 | $396K | 130 |
| 2025-10-29 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 142,000 | ||
| 2025-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
Page 188 of 214 · 4,273 trades